SCHEMBL24247736

SCHEMBL24247736

COC(=O)c1cnn2c(CCC(F)(F)F)c(C)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.39
▸ ALDH1A1 P00352 6/20 0.39
▸ HPGD P15428 5/20 0.39
▸ HSD17B10 Q99714 5/20 0.39
▸ TSHR P16473 3/20 0.39
▸ CASP1 P29466 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ SPR P35270 2/20 0.38
▸ MAPT P10636 4/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ALOX15 P16050 1/20 0.37
▸ CASP7 P55210 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ ESR2 Q92731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127405 0.88 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL24247720 0.85 ALDH1A1 (0.38) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL19150259 0.81 ALDH1A1 (0.36) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL19127945 0.80 KDM4E (0.40) KDM4EALDH1A1HPGD
SCHEMBL20646954 0.76 LMNA (0.38) KDM4EALDH1A1HSD17B10KMT2AMAPT
SCHEMBL19128175 0.76 KDM4E (0.45) KDM4EALDH1A1HSD17B10KMT2ARAB9A
SCHEMBL31389510 0.73 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL20646956 0.73 LMNA (0.36) KDM4EALDH1A1HSD17B10KMT2AMAPT
SCHEMBL24247738 0.72 SPR (0.43) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL23889040 0.71 SLC6A9 (0.35) KDM4EALDH1A1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3954681-A1 SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Bristol-Myers Squibb Company (US) 2022-02-16 — — EP disclosed
Send feedback